Leukemia stem cells (LSCs) pose a significant challenge in treating acute myeloid leukemia (AML) due to their resistance to ...

A new editorial was published in Oncotarget's Volume 15 on October 1, 2024, entitled, "Transplant or no transplant for TP53 ...

In a heartfelt testament to the power of family and community, Amanda Busch, an oncology pharmacist and mother of two, shared ...

Sophie Patnicroft Gray received a stem cell transplant after she was diagnosed in 2019 with acute myeloid leukaemia. Source: Supplied / Leukaemia Foundation of Australia More than 140,000 people ...

The following is a summary of “Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation ...

BUFFALO, NY- October 11, 2024 – A new editorial was published in Oncotarget's Volume 15 on October 1, 2024, entitled, ...

Investigators say adding RNA interference (RNAi) therapy to current treatment modalities may improve outcomes in patients ...

But leukemic stem cells can hide from TKIs in a patient's ... for patients with chronic myeloid leukemia (CML) with molecular evidence of disease (SWOG trial S1712).

But leukemic stem cells can hide from TKIs in a patient ... for patients with chronic myeloid leukemia (CML) with molecular evidence of disease (SWOG trial S1712). Disclaimer: AAAS and EurekAlert!

A recent study evaluates the dosing, safety, and efficacy of telaglenastat and azacytidine to treat advanced myelodysplastic ...

For the event, Walter Klemp, Chairman and Chief Executive Officer, and Dr. Paul Waymack, Senior Chief Medical Officer of ...

The latest high-five for UAMS comes in the form of designating the Winthrop P. Rockefeller Cancer Institute as a "center of excellence" by the Myelodysplastic Syndrome Foundation for its work with ...